Unity Biotechnology, Inc. (UBX)

Unity Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	22	28	39	84	277	331
Market Cap Growth	2.59%	-27.44%	-53.86%	-69.60%	-16.29%	-51.87%
Enterprise Value	8	9	-9	48	239	202
PE Ratio	-	-0.71	-0.87	-1.39	-2.95	-4.03
PS Ratio	-	-	164.78	17.62	-	-
PB Ratio	0.92	0.99	0.69	1.42	3.35	2.74
P/FCF Ratio	-0.78	-0.76	-0.75	-1.86	-3.51	-4.48
P/OCF Ratio	-0.77	-0.76	-0.74	-1.87	-3.54	-4.57
EV/Sales Ratio	-	-	-36.23	10.07	-	-
EV/EBITDA Ratio	-0.32	-0.24	0.22	-0.88	-2.68	-2.54
EV/EBIT Ratio	-0.31	-0.23	0.21	-0.84	-2.58	-2.46
EV/FCF Ratio	-0.33	-0.23	0.16	-1.06	-3.02	-2.73
Debt / Equity Ratio	0.94	0.83	0.84	0.88	0.71	-
Debt / EBITDA Ratio	-0.70	-0.65	-1.22	-0.96	-0.66	-
Debt / FCF Ratio	-0.73	-0.64	-0.91	-1.16	-0.75	-
Quick Ratio	4.70	5.51	4.83	5.33	6.76	7.49
Current Ratio	4.98	5.95	4.92	5.45	6.97	7.52
Asset Turnover	0	0	0.00	0.04	0	0
Interest Coverage	-22.99	-15.26	-11.50	-18.11	-71.63	-
Return on Equity (ROE)	-100.80%	-92.40%	-79.00%	-92.30%	-94.20%	-64.60%
Return on Assets (ROA)	-47.20%	-45.50%	-37.80%	-45.40%	-57.40%	-54.10%
Return on Capital (ROIC)	-89.30%	-86.00%	-55.66%	-50.55%	-66.22%	-74.27%
Earnings Yield	-158.14%	-141.26%	-114.35%	-72.05%	-33.85%	-24.81%
FCF Yield	-140.18%	-131.07%	-134.06%	-53.70%	-28.49%	-22.34%
Buyback Yield / Dilution	-17.27%	-55.60%	-70.10%	-9.73%	-16.60%	-54.32%
Total Shareholder Return	-17.27%	-55.60%	-70.10%	-9.73%	-16.60%	-54.32%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).